Market cap
$129,180 Mln
Revenue (TTM)
$37,542 Mln
P/E Ratio
24.8
P/B Ratio
2.6
Div. Yield
2.8 %
| Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
129,180 | 58,757 | 49,051 | 48,964 | 11,913 |
Revenue ($ Mln) |
37,542 | 19,457 | 7,372 | 3,458 | 4,237 |
Net Profit ($ Mln) |
5,230.00 | 1,146.00 | 1,440.00 | 1,014.77 | 570.30 |
Net Margin (%) |
13.93 | 5.66 | 19.53 | 29.34 | 13.46 |
RoE (%) |
10.47 | 4.58 | 20.18 | 13.86 | 6.83 |
Price to Earnings |
24.81 | 42.63 | 34.11 | 49.58 | 21.38 |
Price-To-Book |
2.59 | 2.37 | 6.62 | 6.64 | 1.42 |
Income Statement ($ Mln)
| Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
36,364.00 | 19,457.00 | 6,948.00 | 3,195.31 | 4,092.40 |
|
Cost of Revenue
|
12,721.00 | 10,243.00 | 3,305.00 | 782.02 | 1,609.50 |
|
Gross Profit
|
23,643.00 | 9,214.00 | 3,643.00 | 2,413.29 | 2,482.90 |
|
Operating Expenses
|
17,179.00 | 6,958.00 | 2,164.00 | 1,496.92 | 1,800.00 |
|
Operating Profit (EBIT)
|
6,467.00 | 2,256.00 | 1,479.00 | 916.37 | 682.90 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
6,136.00 | 1,805.00 | 1,435.00 | 1,194.51 | 566.50 |
|
Provision for Tax
|
1,299.00 | 388.00 | 132.00 | 285.60 | 191.60 |
|
Profit after Tax (Net Income)
|
4,800.00 | 1,146.00 | 1,303.00 | 908.91 | 374.90 |
|
Minority Interest
|
609.00 | -- | -- | -- | 0.20 |
|
Consolidated Profit
|
4,662.00 | 1,678.00 | 1,303.00 | -- | -- |
Liabilities ($ Mln)
| Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
49,463.00 | 24,682.00 | 6,741.00 | 7,214.75 | 8,238.90 |
|
Minority Interest
|
609.00 | -- | -- | -- | 0.20 |
|
Non-Current Liabilities
|
31,298.00 | 16,566.00 | 3,639.00 | 127.54 | 3,042.90 |
|
Current Liabilities
|
11,658.00 | 9,543.00 | 2,347.00 | 1,637.06 | 1,112.80 |
|
Total Liabilities
|
93,028.00 | 50,790.00 | 12,727.00 | 8,979.34 | 12,394.80 |
Assets ($ Mln)
| Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
68,240.00 | 42,474.00 | 8,133.00 | 981.71 | 10,288.40 |
|
Current Assets
|
24,787.00 | 8,316.00 | 4,594.00 | 7,997.63 | 2,106.40 |
|
Total Assets
|
93,028.00 | 50,791.00 | 12,727.00 | 8,979.34 | 12,394.80 |
|
Total Debt*
|
27,961.00 | 16,345.00 | 3,354.00 | 95.86 | 2,783.60 |
|
Net Current Assets
|
13,129.00 | 942.00 | 2,247.00 | 6,360.57 | 993.60 |
Cashflow ($ Mln)
| Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
7,330.00 | 3,365.00 | 1,559.00 | 1,415.23 | 796.10 |
|
Cash Flow from Investing Activities
|
-2,934.00 | -1,048.00 | -394.00 | -1,104.36 | -372.90 |
|
Cash from Financing Activities
|
-4,751.00 | -2,164.00 | -715.00 | -9.33 | -425.90 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
6.24 | 2.68 | 13.32 | 13.75 | 3.46 |
|
ROE (%)
|
9.85 | 4.58 | 20.62 | 13.93 | 4.59 |
|
ROA (%)
|
5.20 | 2.16 | 10.61 | 11.14 | 3.03 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
13.20 | 5.89 | 18.75 | 28.44 | 9.16 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.08 | -0.11 | 0.07 | 0.16 | 0.05 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
2.96 | -31.70 | 1.09 | 27.27 | -4.44 |
|
EPS Growth (%)
|
-- | -0.28 | -- | -- | -- |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | 42.81 | -- | -- | -- |
|
Price / Book Value
|
-- | 1.99 | -- | -- | -- |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
1.91 | 14.04 | 0.85 | -5.19 | 2.54 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.57 | 0.66 | 0.50 | 0.01 | 0.34 |
|
Short term debt to equity ratio
|
0.04 | 0.12 | 0.05 | 0.00 | 0.01 |
|
Current Ratio
|
2.13 | 0.87 | 1.96 | 4.89 | 1.89 |
|
Quick Ratio
|
1.62 | 0.54 | 1.52 | -- | 1.13 |
|
Interest Coverage
|
9.58 | 4.20 | 13.81 | -- | 6.30 |
Operating Efficiency Ratios
| Medtronic PLC (MDT) | Becton Dickinson and Company (BDX) | Agilent Technologies (A) | Veeva Systems Inc. Class A (VEEV) | Cooper Companies Inc (COO) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
18.27 | 14.24 | 21.40 | 41.01 | 20.26 |
|
Asset Turnover
|
0.39 | 0.37 | 0.57 | 0.39 | 0.33 |
|
Receivable days
|
66.08 | 54.11 | 73.89 | 135.31 | 68.99 |
|
Inventory Days
|
164.05 | 126.32 | 111.40 | -- | 187.07 |
|
Payable days
|
73.12 | 70.39 | 61.34 | 15.90 | 63.64 |
|
Cash Conversion Cycle
|
157.01 | 110.04 | 123.95 | -- | 192.42 |